Cancer drug a major breakthrough -- but it has a hefty price tag

US health regulators have approved a revolutionary new drug that uses a patient’s own cells to fight cancer – but it costs $475,000. Pharma giant Novartis on Wednesday won highly anticipated US approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, an exhorbitantly priced treatment that nevertheless marks the start...